Biologic and prognostic significance of HER2-low and ER-low expressions in de novo metastatic breast cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does ...
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene–Driven Non–Small Cell Lung Cancer (TURBO-NSCLC) We develop a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果